Secondary |
Back Pain |
17.2% |
Drug Use For Unknown Indication |
12.9% |
Pain |
8.6% |
Product Used For Unknown Indication |
6.0% |
Bone Pain |
5.2% |
Breast Cancer Metastatic |
5.2% |
Type 2 Diabetes Mellitus |
5.2% |
Rheumatic Disorder |
4.3% |
Analgesic Therapy |
3.4% |
Anxiety Disorder |
3.4% |
Arthropathy |
3.4% |
Dyspepsia |
3.4% |
Hypercholesterolaemia |
3.4% |
Osteoarthritis |
3.4% |
Depression |
2.6% |
Erectile Dysfunction |
2.6% |
Hypertension |
2.6% |
Nausea |
2.6% |
Psoriatic Arthropathy |
2.6% |
Epilepsy |
1.7% |
|
Weight Decreased |
14.6% |
Hepatic Enzyme Increased |
9.8% |
Rash |
7.3% |
Deafness |
4.9% |
Hepatotoxicity |
4.9% |
Liver Function Test Abnormal |
4.9% |
Liver Injury |
4.9% |
Neoplasm Progression |
4.9% |
Pregnancy |
4.9% |
Pulmonary Hypertension |
4.9% |
Somnolence |
4.9% |
Suicide Attempt |
4.9% |
Umbilical Hernia |
4.9% |
Vomiting |
4.9% |
Circulatory Collapse |
2.4% |
Hepatitis |
2.4% |
Nasopharyngitis |
2.4% |
Nausea |
2.4% |
Tachycardia |
2.4% |
Thrombin Time Prolonged |
2.4% |
|
Concomitant |
Drug Use For Unknown Indication |
20.8% |
Rheumatoid Arthritis |
13.4% |
Hypertension |
10.4% |
Product Used For Unknown Indication |
9.7% |
Pain |
9.4% |
Osteoporosis |
8.4% |
Back Pain |
4.4% |
Depression |
4.4% |
Prostate Cancer |
4.0% |
Diarrhoea |
2.0% |
Multiple Sclerosis |
2.0% |
Leukocytosis |
1.7% |
Neuralgia |
1.7% |
Migraine |
1.3% |
Renal Transplant |
1.3% |
Bladder Dysfunction |
1.0% |
Bone Disorder |
1.0% |
Breast Cancer |
1.0% |
Colon Cancer Metastatic |
1.0% |
Contraception |
1.0% |
|
Tooth Loss |
8.9% |
Hepatitis Acute |
7.1% |
Epilepsy |
5.4% |
Gastrointestinal Haemorrhage |
5.4% |
Liver Function Test Abnormal |
5.4% |
Pain |
5.4% |
Pneumonia |
5.4% |
Renal Failure Acute |
5.4% |
Sepsis |
5.4% |
Squamous Cell Carcinoma |
5.4% |
Suicide Attempt |
5.4% |
Syncope |
5.4% |
Vertigo Positional |
5.4% |
Anaemia |
3.6% |
Autoimmune Thrombocytopenia |
3.6% |
Electrocardiogram Qt Prolonged |
3.6% |
Haematoma |
3.6% |
Hepatitis |
3.6% |
Hypercalcaemia |
3.6% |
Hypersensitivity |
3.6% |
|
Interacting |
Product Used For Unknown Indication |
50.0% |
Pain |
30.0% |
Thrombosis Prophylaxis |
20.0% |
|
Hepatitis Acute |
75.0% |
Rhabdomyolysis |
25.0% |
|